Navigation Links
Astellas Signs Distribution Agreement With Tecnofarma For Enzalutamide In Latin America
Date:6/5/2013

prostate cancer in the setting of medical or surgical castration who have received docetaxel therapy. Marketing applications for XTANDI have also been submitted in Japan, Europe, Switzerland, South Korea and Brazil. 

Important Safety Information for XTANDI
Contraindications- XTANDI can cause fetal harm when administered to a pregnant woman based on its mechanism of action. XTANDI is not indicated for use in women. XTANDI is contraindicated in women who are or may become pregnant.

Warnings and Precautions- In the randomized clinical trial, seizure occurred in 0.9% of patients on XTANDI. No patients on the placebo arm experienced seizure. Patients experiencing a seizure were permanently discontinued from therapy. All seizures resolved. Patients with a history of seizure, taking medications known to decrease the seizure threshold, or with other risk factors for seizure were excluded from the clinical trial. Because of the risk of seizure associated with XTANDI use, patients should be advised of the risk of engaging in any activity where sudden loss of consciousness could cause serious harm to themselves or others.

Adverse Reactions- The most common adverse drug reactions (≥ 5%) reported in patients receiving XTANDI in the randomized clinical trial were asthenia/fatigue, back pain, diarrhea, arthralgia, hot flush, peripheral edema, musculoskeletal pain, headache, upper respiratory infection, muscular weakness, dizziness, insomnia, lower respiratory infection, spinal cord compression and cauda equina syndrome, hematuria, paresthesia, anxiety, and hypertension. Grade 1-4 neutropenia occurred in 15% of XTANDI patients (1% Grade 3-4) and in 6% on placebo (no Grade 3-4). Grade 1-4 elevations in bilirubin occurred in 3% of XTANDI patients and 2% on placebo. One percent of XTANDI patients compared to 0.3% on placebo died from infections o
'/>"/>

SOURCE Astellas Pharma US, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. First sales of DIFICLIR™ by Astellas Pharma Europe triggers 10 Million Euro Milestone Payment to Optimer Pharmaceuticals
2. Astellas and Fujita Health University Discover Neuronal Maturation Deficits in Patients Suffering from Schizophrenia and Bipolar Disorder
3. Astellas to Close Urogenix, North Carolina-based Urology Research Facility
4. Personal Connections Drive Employee Participation For Changing Tomorrow Day at Astellas
5. Astellas Announces Acceptance of U.S. New Drug Application for Tacrolimus Extended Release Capsules
6. Ambit and Astellas Announce Presentation of Results from Phase 2 ACE Study of Quizartinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) at the 54th Annual Meeting of the American Society of Hematology
7. Astellas Highlights Progress to Advance Care of Patients with Genitourinary Cancers at ASCO-GU Annual Meeting
8. Astellas to Drive PGA TOURs New Womens Initiative
9. PGA TOUR Celebrates Official Launch of the Astellas Presents Executive Womens Day Program
10. Astellas and Ambit to End Collaboration for Joint Development and Commercialization of FLT3 Kinase Inhibitors
11. Astellas Pharma Inc.: New Hire Reinforces Global Compliance Structure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... 28, 2015 National Community Pharmacists Association (NCPA) ... the following statement in response to a new ... documenting that a number of generic drug costs increased ... with concerns previously expressed by NCPA and underscores the ... to essential medications. Moreover, a 2015 survey of 700 ...
(Date:5/28/2015)... , May 27, 2015 The amount ... billion in 2014 and with growth of 8% will ... categories out of pocket: directly on expenditures, co-pays as ... purchases, and on premiums.  The publisher made its finding ... in the United States . ...
(Date:5/28/2015)...  The U.S. Department of Justice (DOJ) has entered ... Medical Inc. to resolve a lawsuit that began more ... whistleblower lawsuit by two former employees of Orbit.  The ... of one of Orbit,s top executives, Jake Kilgore ... payment from Medicare for electric wheelchairs.  The lawsuit was ...
Breaking Medicine Technology:NCPA: AARP Drug Pricing Report Reiterates Need for Fair Generic Drug Reimbursements 2Report: U.S. Out-of-Pocket Healthcare Spending Reaches $416 Billion 2Report: U.S. Out-of-Pocket Healthcare Spending Reaches $416 Billion 3Electric Wheelchair Sellers Agree To $7.5 Million Settlement Of Whistleblower Case Alleging That Company Forged Medical Records As Part Of Scheme To Defraud Medicare 2Electric Wheelchair Sellers Agree To $7.5 Million Settlement Of Whistleblower Case Alleging That Company Forged Medical Records As Part Of Scheme To Defraud Medicare 3Electric Wheelchair Sellers Agree To $7.5 Million Settlement Of Whistleblower Case Alleging That Company Forged Medical Records As Part Of Scheme To Defraud Medicare 4
... 2011 IsoRay, Inc. (AMEX: ISR ), ... and medical radioisotope applications for brain cancer, lung cancer, ... that Dwight Babcock, Chairman and Chief Executive Officer, will ... 2011 TIME:  5:00 PM EST LINK:   ...
... 2011  myMatrixx®, a full-service pharmacy and ancillary medical ... myRisk Predictor™ a patent-pending revolutionary risk assessment tool ... high risk for potential abuse and misuse of ... historical data and unique algorithms developed by the ...
Cached Medicine Technology:IsoRay, Inc. to Webcast, Live, at RetailInvestorConferences.com on December 1st 2myMatrixx Launches myRisk Predictor™ a Patent-Pending Risk Assessment Tool 2
(Date:5/28/2015)... 28, 2015 The Clinical Data ... that the International Organization for Standardization (ISO) now ... (BRIDG) Model version 3.2 as a published, Final ... with healthcare. This standard, which had previously passed ... was unanimously approved on 24 April for publication ...
(Date:5/28/2015)... 28, 2015 Park Cities Pet Sitter is ... Training class starting Saturday, June 6th at 10:30am. ... 5831 McCommas Blvd in Dallas, with a maximum of six ... for five weeks, with no class being held over the ... $135. , In this Intermediate-to-Advanced level class, dogs will solidify ...
(Date:5/28/2015)... Scotch Plains, NJ (PRWEB) May 28, 2015 ... opening a new location for his Shore Vascular & Vein ... treatment of the circulatory system. It is his mission ... compassion, consideration and respect. , Dr. Jeffrey Gosin ... a graduate of the University of Pennsylvania and Jefferson Medical ...
(Date:5/28/2015)... May 28, 2015 AMVETS leaders this ... prize winner Robert Davis of Newark, Del. AMVETS National ... him on winning the $10,000 sweepstakes grand prize. , ... 100,000 entries from around the country for prizes ranging ... took place on May 21 at the AMVETS National ...
(Date:5/28/2015)... 2015 Medelis, Inc., a specialty oncology ... company in the role of president. , “ Bill Taaffe ... CRO industry,” said Larry Flanagan, Medelis’ CEO and co-founder. “He ... our next phase of growth.” , Taaffe joined ICON’s ... nine employees to over 4,500 employees, achieving 12 consecutive years ...
Breaking Medicine News(10 mins):Health News:CDISC Announces BRIDG Model for Research as Final ISO Standard 2Health News:CDISC Announces BRIDG Model for Research as Final ISO Standard 3Health News:Dallas-based Park Cities Pet Sitter to Offer “Training and Enrichment 2” Group Dog Training Class Beginning Saturday, June 6th, 2015. 2Health News:Dallas-based Park Cities Pet Sitter to Offer “Training and Enrichment 2” Group Dog Training Class Beginning Saturday, June 6th, 2015. 3Health News:Dr. Jeffrey Gosin is Celebrating Three Years at his Somers Point Location! 2Health News:Dr. Jeffrey Gosin is Celebrating Three Years at his Somers Point Location! 3Health News:AMVETS Announces Summer Sweepstakes Winners 2Health News:Bill Taaffe, Former President and CEO of ICON Clinical Research-US, Joins Medelis, a Specialty Oncology CRO, in the Role of President 2
... plays a major role in kidney failure, and blocking the ... disease in diabetes, according to researchers. "We believe these ... can slow down the progression of, or even prevent the ... professor of nephrology, Penn State College of Medicine. In the ...
... News) -- Low vitamin D levels are common among spine ... says. Vitamin D helps with calcium absorption. Spine surgery ... producing new bone, explained researchers at Washington University School of ... spinal fusion surgery and found that more than half of ...
... , FRIDAY, Nov. 4 (HealthDay News) -- "Leatherhead" football ... modern helmets, a new study reports, but no one is ... researchers said their findings point to the need for improvements ... research team conducted lab tests to compare head injury risks ...
... crystallography, researchers Xiaohu Mei, PhD, and David Atkinson, PhD, from ... time obtained an "image" of the structure and the precise ... apolipoprotein A-I (apoA-I) molecule. The findings, which appear in the ... may lead to the development of new drugs to treat ...
... a new study being published early online in Annals ... College of Physicians, birth cohort screening for hepatitis C is ... strategy could identify over 800,000 currently unidentified cases, which could ... percent of the nation,s population is infected with hepatitis C ...
... A gene variation associated with an increased risk of autism ... three to four times more likely than girls to be ... genomic data from more than 3,000 children with autism and ... The results showed a link between a variation in the ...
Cached Medicine News:Health News:Research aims to prevent diabetic kidney failure 2Health News:Vitamin D Lacking in Many Spine Surgery Patients 2Health News:Newer Not Necessarily Better for Football Helmet Design 2Health News:Researchers identify structure of apolipoprotein 2Health News:Birth cohort screening for hepatitis C is cost effective, could save thousands of lives each year 2Health News:Possible Genetic Link to Autism Identified 2
An economical solution to the need to provide wrap-around protection. The one-sided velcro closure allows greater flexibility in sizing. Front protection is 0.5mm Pb and the back is 0.25mm Pb equival...
This wrap around apron features a uniquely designed orthopedic wide belt that is integrated directly on the apron....
The most comfortable and easy to use apron in the industry. This front protection apron comes with a fully adjustable snap-on 5" orthopedic belt to relieve weight off your shoulders. Velcro strap acr...
Unique criss-cross strapping. The MSV-10 is our most popular model. Extra wide Velcro ensures a wide variety of adjustments and easy closing....
Medicine Products: